Expansion Opportunities Atomo Diagnostics has been expanding its footprint across Australia, New Zealand, and Oceania, with recent office growth and government-backed HIV self-test orders. This signals a growing regional demand for rapid infectious disease testing and presents sales opportunities for distribution partnerships, local supply agreements, and expanded catalog offerings in new markets.

Public Sector Demand Significant government funding and orders, including a $440k Australian government-backed HIV self-test order and a $2.44M CRCs grant for rapid syphilis testing, indicate strong public sector procurement potential. Opportunities exist to pursue tenders, contract manufacturing, and long-term supply arrangements with health ministries and public health agencies.

Strategic Partnerships A history of collaborations with Burnet Institute and Viatris demonstrates a readiness to engage in co-development and distribution agreements. This suggests potential for joint ventures, co-branded tests, and scalable manufacturing partnerships to meet rising demand in diverse markets.

Product Portfolio Fit With a focus on convenient, user-friendly rapid tests such as HIV self-tests and ongoing syphilis diagnostics, there is a strong alignment with retailers, clinics, and telehealth channels seeking reliable point-of-care and at-home testing solutions. Opportunities exist for channel partners in retail pharmacies, clinics, and e-commerce platforms.

Scale-Up Readiness Recent financing rounds and plans to scale Pascal cassette supply amid expected demand growth indicate capacity to ramp manufacturing. This creates sales opportunities for volume-based contracts, preferred supplier agreements, and inventory financing for large-scale distribution programs.